An alert from the United Nations has successfully stopped a shipment of precursor chemicals that could have been used to produce an estimated 1.6 billion lethal doses of fentanyl. This interception underscores the critical role of international cooperation in combating the ever-changing landscape of the illegal drug trade.
According to the International Narcotics Control Board (INCB)’s 2025 Annual Report, authorities utilized its pre-export notification platform to prevent the diversion of three tons of 1-boc-4-piperidone, a key chemical intermediate in fentanyl manufacturing. The intercepted shipment, had it reached its destination, could have yielded between 1.4 to 3.3 tons of fentanyl, equivalent to 700 million to 1.6 billion doses of the potent synthetic opioid.
This successful operation in March 2025 is highlighted by the INCB as a prime example of an “international success story” driven by collaboration. Professor Sevil Atasoy, President of the INCB, emphasized the enduring effectiveness of the drug control conventions, a framework that has fostered global cooperation for over six decades. “Our role is to reinforce the cooperative efforts of countries and territories through our work,” she stated.
A System Built on Cooperation
The INCB, an independent and quasi-judicial body, monitors the implementation of the three core international drug control conventions established in 1961, 1971, and 1988. These treaties form the foundation of the global drug control system, requiring governments to submit data on the cultivation, manufacture, and trade of controlled substances. The INCB’s mandate ensures these substances are available for legitimate medical and scientific purposes while preventing their diversion into illicit markets.
The INCB report indicates that this system has been highly effective, keeping the diversion of narcotic drugs into illegal channels “very low” and virtually eliminating the diversion of psychotropic substances like heroin and other opioids. In 2025, over 190 countries and territories collaborated through the online pre-export notification (PEN) platform, overseeing more than 34,000 planned shipments of controlled drug precursors.
New Threats and Shifting Markets
Despite these successes, the INCB warns that trafficking networks are rapidly adapting to new challenges. Cocaine trafficking continues to be the fastest-growing illicit drug market, with increased production in South America fueling expansion into Asia and Africa. In Europe, cocaine trafficking to Western and Central regions has seen a dramatic rise, alongside the continued expansion of illicit synthetic drug manufacturing.
While North America has reported decreases in synthetic drug overdoses—17% in Canada and 27% in the United States—the INCB cautions that it is premature to determine if this trend is sustainable. In Africa, the trafficking of pharmaceutical opioids, including substandard products, is a significant concern. The South Asian region accounts for a substantial portion of the world’s estimated opioid users, and methamphetamine remains the primary synthetic drug threat in East and Southeast Asia, with record seizures being reported.
Uneven Access to Medicines
The Board also highlighted persistent inequalities in access to essential pain relief medicines, particularly in low- and middle-income countries, even as the global supply of opioid painkillers remains stable. Many nations continue to face difficulties in procuring morphine-containing medications, and increasing the availability and affordability of psychotropic substances remains a priority. “Protecting the health of people around the world from the dangers of illicit drugs is a common and shared responsibility,” Professor Atasoy concluded. “The international drug control system relies on the willingness and capacity of countries to work together.”
